IsoRay, Inc. (NYSEMKT:ISR)

CAPS Rating: 1 out of 5

The Company develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases.


Player Avatar OklaBoston (68.01) Submitted: 3/20/2014 4:43:00 PM : Outperform Start Price: $2.78 ISR Score: +21.97

I believe this is bottoming out and recent open market insider buys reinforce that belief.

Featured Broker Partners